Century Therapeutics, Inc. (IPSC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Century Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.99x | -0.63x | -1.44x | -2.26x | -9.10x | -23.36x |
| P/B Ratio | 0.54x | 0.49x | 1.07x | 0.98x | 2.20x | -11.76x |
| P/S Ratio | 0.79x | 12.06x | 88.11x | 56.99x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 88.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% |
| Operating Margin | -13.8% | -2096.5% | -6556.9% | -2574.2% | 0.0% | 0.0% |
| Net Margin | -8.8% | -1920.9% | -6115.1% | -2518.4% | 0.0% | 0.0% |
| EBITDA Margin | -1.8% | -1691.8% | -5423.2% | -2331.2% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.97x | 1.50x | 9.92x | 10.72x | 14.57x | 6.51x |
| Quick Ratio | 5.97x | 1.50x | 9.92x | 10.72x | 14.57x | 6.51x |
| Leverage | ||||||
| Debt/Equity | 0.27x | 0.33x | 0.26x | 0.16x | 0.06x | -0.20x |
YoY = year-over-year change. Source: FMP..